4.6 Article

Long-Term Clinical Impact of Coronary CT Angiography in Patients With Recent Acute-Onset Chest Pain The Randomized Controlled CATCH Trial

期刊

JACC-CARDIOVASCULAR IMAGING
卷 8, 期 12, 页码 1404-1413

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2015.07.015

关键词

acute chest pain; clinical outcome; coronary artery disease; coronary computed tomographic angiography; exercise electrocardiogram

资金

  1. Danish Heart Foundation, Copenhagen, Denmark [12-04-R90_A3921-22718]
  2. John and Birthe Meyer Foundation, Copenhagen, Denmark
  3. AP Moller and Chastine Mc-Kinney Moller Foundation, Copenhagen, Denmark
  4. Toyota Foundation, Copenhagen, Denmark
  5. Danish Agency for Science, Technology, and Innovation by The Danish Council for Strategic Research (Eastern Denmark Initiative to imprOve Revascularization Strategies grant), Copenhagen, Denmark [09-066994]
  6. Toshiba Medical Systems
  7. Toshiba Medical Corporation
  8. AP Moller og hustru Chastine McKinney, Meiners Fond
  9. John and Birthe Meyer Foundation
  10. Research Council of Rigshopitalet
  11. University of Copenhagen
  12. Danish Heart Foundation
  13. Lundbeck Foundation
  14. Danish Agency for Science, Technology and Innovation by The Danish Council for Strategic Research

向作者/读者索取更多资源

OBJECTIVES The aim of the CATCH (CArdiac CT in the treatment of acute CHest pain) trial was to investigate the long-term clinical impact of a coronary computed tomographic angiography (CTA)-guided treatment strategy in patients with recent acute-onset chest pain compared to standard care. BACKGROUND The prognostic implications of a coronary CTA-guided treatment strategy have not been compared in a randomized fashion to standard care in patients referred for acute-onset chest pain. METHODS Patients with acute chest pain but normal electrocardiograms and troponin values were randomized to treatment guided by either coronary CTA or standard care (bicycle exercise electrocardiogram or myocardial perfusion imaging). In the coronary CTA-guided group, a functional test was included in cases of nondiagnostic coronary CTA images or coronary stenoses of borderline severity. The primary endpoint was a composite of cardiac death, myocardial infarction (MI), hospitalization for unstable angina pectoris (UAP), Late symptom-driven revascularizations, and readmission for chest pain. RESULTS We randomized 299 patients to coronary CTA-guided strategy and 301 to standard care. After inclusion, 24 patients withdrew their consent. The median (interquartile range) follow-up duration was 18.7 (range 16.8 to 20.1) months. In the coronary CTA-guided group, 30 patients (11%) had a primary endpoint versus 47 patients (16%) in the standard care group (p = 0.04; hazard ratio [HR]: 0.62 [95% confidence interval: 0.40 to 0.98]). A major adverse cardiac event (cardiac death, MI, hospitalization for UAP, and late symptom-driven revascularization) was observed in 5 patients (2 Mls, 3 UAPs) in the coronary CTA-guided group versus 14 patients (1 cardiac death, 7 Mls, 5 UAPs, 1 Late symptom-driven revascularization) in the standard care group (p = 0.04; HR: 0.36 [95% CI: 0.16 to 0.95]). Differences in cardiac death and MI (8 vs. 2) were insignificant (p = 0.06). CONCLUSIONS A coronary CTA-guided treatment strategy appears to improve clinical outcome in patients with recent acute-onset chest pain and normal electrocardiograms and troponin values compared to standard care with a functional test. (Cardiac-CT in the Treatment of Acute Chest Pain [CATCH]; NCT01534000) (C) 2015 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据